Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone for Olfactory Dysfunction in Seasonal Allergic Rhinitis
NCT00361439Phase 4Terminated
- Sponsor
- University of Chicago
- Start
- Aug 2006
- Primary completion
- Sep 2008
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Mometasone furoate nano-nasal spray in seasonal allergic rhinitis (SAR) (2 arms), sponsored by University of Chicago. Primary endpoint: Histological Findings at 2 weeks. Started Aug 2006; status: terminated.
02
Drugs
Mometasone furoate nano-nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00361439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361439.